Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
